Novel tear film supplements: a potential application for synthetic protein-phospholipid complexes

Darren Campbell, Anisa Mahomed, Nadia Rasul, Marc Broadbent, Brian Tighe

Research output: Contribution to conferencePoster

Abstract

Purpose: Surfactant proteins A, B, C and D complex with (phospho)lipids to produce surfactants which provide low interfacial tensions. It is likely that similar complexation occurs in the tear film and contributes to its low surface tension. Synthetic protein-phospholipid complexes, with styrene maleic anhydrides (SMAs) as the protein analogue, have been shown to have similarly
low surface tensions. This study investigates the potential of modified SMAs and/or SMA-phospholipid complexes, which form under physiological conditions, to supplement natural tear film surfactants.
Method: SMAs were modified to provide structural variants which can form complexes under varying conditions. Infrared spectroscopy and Nuclear Magnetic Resonance were used to confirm SMA structure. Interfacial behaviour of the SMA and SMA-phospholipid complexes was studied using Langmuir trough, du Nûoy ring and pulsating bubblemethods. Factors which
affect SMA-phospholipid complex formation, such as temperature and pH, were also investigated.
Results: Structural manipulation of SMAs allows control over complex formation, including under physiological conditions (e.g. partial SMAesterfication allowed complexation with dimyristoylphosphatidylcholine, at pH7). The low surface tensions of the SMAs (42mN/m for static (du Nûoy ring) and 34mN/m for dynamic (Langmuir) techniques) demonstrate their
surface activity at the air-aqueous interface. SMA-phospholipid complexes provide even lower surface tensions (~2 mN/m), approaching that of lung surfactant, as measured by the pulsating bubblemethod.
Conclusions: Design of the molecular architecture of SMAs allows control over their surfactant properties. These SMAs could be used as novel tear films supplements, either alone to complex with native tear film phospholipids or delivered as synthetic protein-phospholipid complexes.
Original languageEnglish
Publication statusPublished - 2011
EventBritish Contact Lens Association - Birmingham, United Kingdom
Duration: 27 May 201030 May 2010

Conference

ConferenceBritish Contact Lens Association
CountryUnited Kingdom
CityBirmingham
Period27/05/1030/05/10

Fingerprint

Maleic Anhydrides
Styrene
Phospholipids
Proteins
Surface tension
Surface-Active Agents
Complexation
Pulmonary Surfactant-Associated Protein A
Dimyristoylphosphatidylcholine

Bibliographical note

Abstract published on Abstracts of the 2011 BCLA Annual Clinical Conference / Contact Lens & Anterior Eye 34, Supplement 1 (2011) S18 DOI http://dx.doi.org/10.1016/S1367-0484(11)60086-6

Cite this

Campbell, D., Mahomed, A., Rasul, N., Broadbent, M., & Tighe, B. (2011). Novel tear film supplements: a potential application for synthetic protein-phospholipid complexes. Poster session presented at British Contact Lens Association, Birmingham, United Kingdom.
Campbell, Darren ; Mahomed, Anisa ; Rasul, Nadia ; Broadbent, Marc ; Tighe, Brian. / Novel tear film supplements : a potential application for synthetic protein-phospholipid complexes. Poster session presented at British Contact Lens Association, Birmingham, United Kingdom.
@conference{661c2765070341519660d3d398aabb85,
title = "Novel tear film supplements: a potential application for synthetic protein-phospholipid complexes",
abstract = "Purpose: Surfactant proteins A, B, C and D complex with (phospho)lipids to produce surfactants which provide low interfacial tensions. It is likely that similar complexation occurs in the tear film and contributes to its low surface tension. Synthetic protein-phospholipid complexes, with styrene maleic anhydrides (SMAs) as the protein analogue, have been shown to have similarlylow surface tensions. This study investigates the potential of modified SMAs and/or SMA-phospholipid complexes, which form under physiological conditions, to supplement natural tear film surfactants.Method: SMAs were modified to provide structural variants which can form complexes under varying conditions. Infrared spectroscopy and Nuclear Magnetic Resonance were used to confirm SMA structure. Interfacial behaviour of the SMA and SMA-phospholipid complexes was studied using Langmuir trough, du N{\^u}oy ring and pulsating bubblemethods. Factors whichaffect SMA-phospholipid complex formation, such as temperature and pH, were also investigated.Results: Structural manipulation of SMAs allows control over complex formation, including under physiological conditions (e.g. partial SMAesterfication allowed complexation with dimyristoylphosphatidylcholine, at pH7). The low surface tensions of the SMAs (42mN/m for static (du N{\^u}oy ring) and 34mN/m for dynamic (Langmuir) techniques) demonstrate theirsurface activity at the air-aqueous interface. SMA-phospholipid complexes provide even lower surface tensions (~2 mN/m), approaching that of lung surfactant, as measured by the pulsating bubblemethod.Conclusions: Design of the molecular architecture of SMAs allows control over their surfactant properties. These SMAs could be used as novel tear films supplements, either alone to complex with native tear film phospholipids or delivered as synthetic protein-phospholipid complexes.",
author = "Darren Campbell and Anisa Mahomed and Nadia Rasul and Marc Broadbent and Brian Tighe",
note = "Abstract published on Abstracts of the 2011 BCLA Annual Clinical Conference / Contact Lens & Anterior Eye 34, Supplement 1 (2011) S18 DOI http://dx.doi.org/10.1016/S1367-0484(11)60086-6; British Contact Lens Association ; Conference date: 27-05-2010 Through 30-05-2010",
year = "2011",
language = "English",

}

Campbell, D, Mahomed, A, Rasul, N, Broadbent, M & Tighe, B 2011, 'Novel tear film supplements: a potential application for synthetic protein-phospholipid complexes' British Contact Lens Association, Birmingham, United Kingdom, 27/05/10 - 30/05/10, .

Novel tear film supplements : a potential application for synthetic protein-phospholipid complexes. / Campbell, Darren; Mahomed, Anisa; Rasul, Nadia; Broadbent, Marc; Tighe, Brian.

2011. Poster session presented at British Contact Lens Association, Birmingham, United Kingdom.

Research output: Contribution to conferencePoster

TY - CONF

T1 - Novel tear film supplements

T2 - a potential application for synthetic protein-phospholipid complexes

AU - Campbell, Darren

AU - Mahomed, Anisa

AU - Rasul, Nadia

AU - Broadbent, Marc

AU - Tighe, Brian

N1 - Abstract published on Abstracts of the 2011 BCLA Annual Clinical Conference / Contact Lens & Anterior Eye 34, Supplement 1 (2011) S18 DOI http://dx.doi.org/10.1016/S1367-0484(11)60086-6

PY - 2011

Y1 - 2011

N2 - Purpose: Surfactant proteins A, B, C and D complex with (phospho)lipids to produce surfactants which provide low interfacial tensions. It is likely that similar complexation occurs in the tear film and contributes to its low surface tension. Synthetic protein-phospholipid complexes, with styrene maleic anhydrides (SMAs) as the protein analogue, have been shown to have similarlylow surface tensions. This study investigates the potential of modified SMAs and/or SMA-phospholipid complexes, which form under physiological conditions, to supplement natural tear film surfactants.Method: SMAs were modified to provide structural variants which can form complexes under varying conditions. Infrared spectroscopy and Nuclear Magnetic Resonance were used to confirm SMA structure. Interfacial behaviour of the SMA and SMA-phospholipid complexes was studied using Langmuir trough, du Nûoy ring and pulsating bubblemethods. Factors whichaffect SMA-phospholipid complex formation, such as temperature and pH, were also investigated.Results: Structural manipulation of SMAs allows control over complex formation, including under physiological conditions (e.g. partial SMAesterfication allowed complexation with dimyristoylphosphatidylcholine, at pH7). The low surface tensions of the SMAs (42mN/m for static (du Nûoy ring) and 34mN/m for dynamic (Langmuir) techniques) demonstrate theirsurface activity at the air-aqueous interface. SMA-phospholipid complexes provide even lower surface tensions (~2 mN/m), approaching that of lung surfactant, as measured by the pulsating bubblemethod.Conclusions: Design of the molecular architecture of SMAs allows control over their surfactant properties. These SMAs could be used as novel tear films supplements, either alone to complex with native tear film phospholipids or delivered as synthetic protein-phospholipid complexes.

AB - Purpose: Surfactant proteins A, B, C and D complex with (phospho)lipids to produce surfactants which provide low interfacial tensions. It is likely that similar complexation occurs in the tear film and contributes to its low surface tension. Synthetic protein-phospholipid complexes, with styrene maleic anhydrides (SMAs) as the protein analogue, have been shown to have similarlylow surface tensions. This study investigates the potential of modified SMAs and/or SMA-phospholipid complexes, which form under physiological conditions, to supplement natural tear film surfactants.Method: SMAs were modified to provide structural variants which can form complexes under varying conditions. Infrared spectroscopy and Nuclear Magnetic Resonance were used to confirm SMA structure. Interfacial behaviour of the SMA and SMA-phospholipid complexes was studied using Langmuir trough, du Nûoy ring and pulsating bubblemethods. Factors whichaffect SMA-phospholipid complex formation, such as temperature and pH, were also investigated.Results: Structural manipulation of SMAs allows control over complex formation, including under physiological conditions (e.g. partial SMAesterfication allowed complexation with dimyristoylphosphatidylcholine, at pH7). The low surface tensions of the SMAs (42mN/m for static (du Nûoy ring) and 34mN/m for dynamic (Langmuir) techniques) demonstrate theirsurface activity at the air-aqueous interface. SMA-phospholipid complexes provide even lower surface tensions (~2 mN/m), approaching that of lung surfactant, as measured by the pulsating bubblemethod.Conclusions: Design of the molecular architecture of SMAs allows control over their surfactant properties. These SMAs could be used as novel tear films supplements, either alone to complex with native tear film phospholipids or delivered as synthetic protein-phospholipid complexes.

M3 - Poster

ER -

Campbell D, Mahomed A, Rasul N, Broadbent M, Tighe B. Novel tear film supplements: a potential application for synthetic protein-phospholipid complexes. 2011. Poster session presented at British Contact Lens Association, Birmingham, United Kingdom.